Functionally, HK010 increased the antitumor cytokine release of T cells in a manner strictly dependent on the PD-L1 expression of tumor cells or APCs, thereby facilitating the killing of tumor cells, whereas the anti-4-1BB/PD-L1 antibodies alone or in combination did not exhibit this capacity. This evidence concerns the gene TNFRSF9 and neoplasm.